IRIS Accounts Production v25.4.12.37 06567678 Board of Directors 1.7.24 30.6.25 30.6.25 true false true false false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 06567678 2024-06-30 06567678 2025-06-30 06567678 2024-07-01 2025-06-30 06567678 2023-06-30 06567678 2023-07-01 2024-06-30 06567678 2024-06-30 06567678 ns15:EnglandWales 2024-07-01 2025-06-30 06567678 ns14:PoundSterling 2024-07-01 2025-06-30 06567678 ns10:Director1 2024-07-01 2025-06-30 06567678 ns10:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 06567678 ns10:SmallEntities 2024-07-01 2025-06-30 06567678 ns10:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 06567678 ns10:SmallCompaniesRegimeForDirectorsReport 2024-07-01 2025-06-30 06567678 ns10:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 06567678 ns10:FullAccounts 2024-07-01 2025-06-30 06567678 1 2024-07-01 2025-06-30 06567678 ns5:CurrentFinancialInstruments 2025-06-30 06567678 ns5:CurrentFinancialInstruments 2024-06-30 06567678 ns5:Non-currentFinancialInstruments 2025-06-30 06567678 ns5:Non-currentFinancialInstruments 2024-06-30 06567678 ns5:ShareCapital 2025-06-30 06567678 ns5:ShareCapital 2024-06-30 06567678 ns5:RetainedEarningsAccumulatedLosses 2025-06-30 06567678 ns5:RetainedEarningsAccumulatedLosses 2024-06-30 06567678 ns10:RegisteredOffice 2024-07-01 2025-06-30 06567678 ns5:IntangibleAssetsOtherThanGoodwill 2024-07-01 2025-06-30 06567678 ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-07-01 2025-06-30 06567678 ns5:PlantMachinery 2024-07-01 2025-06-30 06567678 ns5:NetGoodwill 2024-06-30 06567678 ns5:IntangibleAssetsOtherThanGoodwill 2024-06-30 06567678 ns5:NetGoodwill 2025-06-30 06567678 ns5:IntangibleAssetsOtherThanGoodwill 2025-06-30 06567678 ns5:NetGoodwill 2024-06-30 06567678 ns5:IntangibleAssetsOtherThanGoodwill 2024-06-30 06567678 ns5:PlantMachinery 2024-06-30 06567678 ns5:PlantMachinery 2025-06-30 06567678 ns5:PlantMachinery 2024-06-30 06567678 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2024-06-30 06567678 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2024-07-01 2025-06-30 06567678 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2025-06-30 06567678 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2024-06-30 06567678 ns5:CostValuation 2024-06-30 06567678 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-06-30 06567678 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-06-30 06567678 ns5:Secured 2025-06-30 06567678 ns5:Secured 2024-06-30

REGISTERED NUMBER: 06567678 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 June 2025

for

Lockdown Medical Limited

Lockdown Medical Limited (Registered number: 06567678)

Contents of the Financial Statements

for the year ended 30 June 2025

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 3 |

Lockdown Medical Limited (Registered number: 06567678)

Balance Sheet

30 June 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 5 | - |  | - |  |

Tangible assets | 6 | 50,571 |  | 118,106 |  |

Investments | 7 | 103,510 |  | 280,468 |  |

154,081 |  | 398,574 |  |

CURRENT ASSETS

Stocks | 226,843 |  | 353,916 |  |

Debtors | 8 | 433,678 |  | 601,801 |  |

Cash at bank and in hand | 282,405 |  | 44,417 |  |

942,926 |  | 1,000,134 |  |

CREDITORS

Amounts falling due within one year | 9 | 217,165 |  | 335,120 |  |

NET CURRENT ASSETS | 725,761 |  | 665,014 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 879,842 |  | 1,063,588 |  |

CREDITORS

Amounts falling due after more than one year | 10 | 45,833 |  | 114,200 |  |

NET ASSETS | 834,009 |  | 949,388 |  |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | 834,008 |  | 949,387 |  |

834,009 |  | 949,388 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lockdown Medical Limited (Registered number: 06567678)

Balance Sheet - continued

30 June 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 March 2026 and were signed on its behalf by:

M Ellis - Director

Lockdown Medical Limited (Registered number: 06567678)

Notes to the Financial Statements

for the year ended 30 June 2025

1. | STATUTORY INFORMATION

| Lockdown Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 06567678

| Registered office: | 16 The Oaks

| Clews Road

| Redditch

| Worcestershire

| B98 7ST

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements have been prepared under the historical cost convention.

| Preparation of consolidated financial statements

| The financial statements contain information about Lockdown Medical Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Revenue is generated from the sale or temporary hire of orthopaedic instruments and implants, and it is recognised on consumption of stock supplied via loan kits or on consignment, or on despatch of goods for standard sales orders.

| Intangible assets

| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

| Development costs are being amortised evenly over their estimated useful life of five years.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

| Plant and machinery etc | - | 25% on cost

| Investments in subsidiaries

| Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

Lockdown Medical Limited (Registered number: 06567678)

Notes to the Financial Statements - continued

for the year ended 30 June 2025

3. | ACCOUNTING POLICIES - continued

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Research and development

| Expenditure on research and development is written off in the year in which it is incurred.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Hire purchase and leasing commitments

| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 14 (2024 - 14 ) .

Lockdown Medical Limited (Registered number: 06567678)

Notes to the Financial Statements - continued

for the year ended 30 June 2025

5. | INTANGIBLE FIXED ASSETS

| Other |

| intangible |

| Goodwill |  | assets |  | Totals

£ | £ | £ |

| COST

| At 1 July 2024

| and 30 June 2025 | 1,038,531 |  | 260,757 |  | 1,299,288 |  |

| AMORTISATION

| At 1 July 2024

| and 30 June 2025 | 1,038,531 |  | 260,757 |  | 1,299,288 |  |

| NET BOOK VALUE

| At 30 June 2025 | - |  | - |  | - |  |

| At 30 June 2024 | - |  | - |  | - |  |

6. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 July 2024 | 253,573 |  |

| Additions | 8,809 |  |

| Disposals | (86,495 | ) |

| At 30 June 2025 | 175,887 |  |

| DEPRECIATION

| At 1 July 2024 | 135,467 |  |

| Charge for year | 33,844 |  |

| Eliminated on disposal | (43,995 | ) |

| At 30 June 2025 | 125,316 |  |

| NET BOOK VALUE

| At 30 June 2025 | 50,571 |  |

| At 30 June 2024 | 118,106 |  |

Lockdown Medical Limited (Registered number: 06567678)

Notes to the Financial Statements - continued

for the year ended 30 June 2025

6. | TANGIBLE FIXED ASSETS - continued

| Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

| Plant and

| machinery

| etc

£ |

| COST

| At 1 July 2024 | 63,995 |  |

| Disposals | (63,995 | ) |

| At 30 June 2025 | - |  |

| DEPRECIATION

| At 1 July 2024 | 30,664 |  |

| Charge for year | 1,334 |  |

| Eliminated on disposal | (31,998 | ) |

| At 30 June 2025 | - |  |

| NET BOOK VALUE

| At 30 June 2025 | - |  |

| At 30 June 2024 | 33,331 |  |

7. | FIXED ASSET INVESTMENTS

| Shares in

| group

| undertakin

£ |

| COST

| At 1 July 2024

| and 30 June 2025 | 361,845 |  |

| PROVISIONS

| At 1 July 2024 | 81,377 |  |

| Provision for year | 176,958 |  |

| At 30 June 2025 | 258,335 |  |

| NET BOOK VALUE

| At 30 June 2025 | 103,510 |  |

| At 30 June 2024 | 280,468 |  |

Lockdown Medical Limited (Registered number: 06567678)

Notes to the Financial Statements - continued

for the year ended 30 June 2025

8. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 289,494 |  | 298,779 |  |

| Amounts owed by group undertakings | 88,876 |  | 131,619 |  |

| Other debtors | 55,308 |  | 171,403 |  |

433,678 |  | 601,801 |  |

9. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans and overdrafts | 50,000 |  | 50,000 |  |

| Hire purchase contracts | - |  | 7,509 |  |

| Trade creditors | 105,260 |  | 246,691 |  |

| Taxation and social security | 26,639 |  | 15,473 |  |

| Other creditors | 35,266 |  | 15,447 |  |

217,165 |  | 335,120 |  |

10. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans | 45,833 |  | 95,833 |  |

| Hire purchase contracts | - |  | 18,367 |  |

45,833 |  | 114,200 |  |

11. | SECURED DEBTS

| The following secured debts are included within creditors:

2025 | 2024 |

£ | £ |

| Bank loans | 95,833 |  | 145,833 |  |

| Hire purchase contracts | - |  | 25,876 |  |

95,833 |  | 171,709 |  |

| The bank loan is secured by a debenture giving a fixed and floating charge over all the assets of the company.

| The hire purchase creditor is secured against the relevant asset.

12. | RELATED PARTY DISCLOSURES

| During the year, sales of £264,227 (2024: £304,856) were made to Lockdown Surgical Inc., the company's wholly owned US subsidiary. At the balance sheet date, Lockdown Surgical Inc. owed the company (including trade debts) £233,467 (2023: £279,190). Provision of £65,204 (2024: £65,204) has been made against this balance.